Background The virus neutralization assay is a principal method to assess the efficacy of
antibodies in blocking viral entry. Due to biosafety handling requirements of viruses …

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires
ongoing monitoring to judge the ability of newly arising variants to escape the immune …

To understand reinfection rates and correlates of protection for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), we established eight different longitudinal cohorts …

Importance The degree of immune protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) variants provided by infection versus vaccination with wild …

The quantification of neutralising antibodies (NAb) for SARS-CoV-2 has become an
important tool for monitoring protective immunity following infection or immunisation. In this …

Since its emergence in late 2019, coronavirus disease 2019 (COVID‐19) has caused
millions of deaths and socioeconomic losses. Although vaccination significantly reduced …

In light of an increasing number of vaccinated and convalescent individuals, there is a major
need for the development of robust methods for the quantification of neutralizing antibodies; …

Background: Because the regular vaccine campaign started in Guinea one year after the
COVID-19 index case, the profile of naturally acquired immunity following primary SARS …

During the SARS-CoV-2 pandemic, the lack of standardized measurements of the immune
response after vaccination or recovery from COVID-19 resulted in incomparable results and …

Anti-SARS-CoV-2-specific serological responses are a topic of ongoing evaluation studies.
In the study presented here, the anti-SARS-CoV-2 surrogate neutralization assays by …